Jeffery White

Jeffery White has 20 years of experience in clinical development and medical affairs in the pharmaceutical industry. From 2014 to 2016, Dr. White served as a consultant and as VP Clinical Development at Audentes Therapeutics, a rare disease-focused, gene therapy biotech company. From 2006 to 2014, he served as a consultant providing highly-skilled, senior-level physician support to biopharmaceutical companies, including Genentech/Roche, GSK, Biomarin, Sapphire Therapeutics, Rhythm Pharmaceuticals, Morphosys AG, Stiefel Laboratories, and Heron Therapeutics. Dr. White began his industry career at Merck in 1997 as Director of Regulatory Affairs, where he worked on major cardiovascular endpoint trials, IND filings, pediatric exclusivity, a priority review of a NDA and an FDA Advisory Committee Meeting. In his 20 years in the industry, Dr. White has designed and conducted clinical trials in Phases 1 through 4 in a variety of therapeutic areas including inflammatory bowel disease, dermatology, rheumatology, cardiovascular diseases, critical care, neurology, pain, ophthalmology, headache and in multiple orphan diseases, with filings from IND to NDA/BLA. Dr. White received his B.S. from Stanford University and medical training from the University of Washington and Harvard Medical School.

Jeffery White is the Chief Medical Officer at Connect Biopharmaceuticals, based in United States, North America. With a background in Biotechnology, Jeffery White has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.